Xinjiang Zhongtai Chemical Co., Ltd. (002092.SZ)
Ürümqi, CN
Xinjiang Zhongtai Chemical Co., Ltd., founded in 2011 and headquartered in Ürümqi, China, specializes in the production and distribution of a diverse range of chemical substances. Marketing its products primarily under the "Feng" brand within China, the company's portfolio includes polyvinyl chloride (PVC) products, ion-exchange membrane caustic soda, viscose fiber, viscose yarn, and blue carbon. Zhongtai Chemical also manufactures calcium carbide and leverages its calcium carbide slag byproduct for cement production, reflecting its commitment to circular economy industrial chains that also incorporate materials like cotton pulp. Beyond its domestic operations, the company actively exports its chemical goods internationally.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.64% | -8.48% | -33.04% | -38.38% | -2.93% | -6.83% | -0.43% | -31.26% | -53.55% | -39.97% | +2.88% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-5.7% Q1'26: +5.2% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+71.1% ★ Q1'26: -58.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-7.5% Q1'26: -2.5% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+4.0% Q1'26: +1.4% (vs Q1'25)
-
ROIC Chemicals: +3.4%+1.9% Q1'26: +0.8% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×35.40× Q1'26: 84.79× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
41.06B
est: 34.08B (+20.5%)
|
70.22B
est: 55.27B (+27.1%)
|
83.14B
est: 82.90B (+0.3%)
|
84.21B
est: 87.88B (-4.2%)
|
62.89B
est: 57.10B (+10.1%)
|
51.66B
est: 50.96B (+1.4%)
|
37.12B
est: 44.49B (-16.6%)
|
30.12B
est: 48.14B (-37.4%)
|
28.41B
est: 46.74B (-39.2%)
|
30.91B
30.91B – 30.91B
-33.9% YoY
|
32.14B
32.14B – 32.14B
+4.0% YoY
|
33.17B
33.17B – 33.17B
+3.2% YoY
|
| EBITDA |
5.32B
est: 2.74B (+94.3%)
|
5.54B
est: 4.44B (+24.7%)
|
3.77B
est: 6.67B (-43.4%)
|
3.27B
est: 7.07B (-53.7%)
|
7.18B
est: 4.59B (+56.5%)
|
4.58B
est: 4.10B (+11.8%)
|
1.45B
est: 3.58B (-59.5%)
|
3.65B
est: 3.88B (-5.9%)
|
1.14B
est: 3.77B (-69.7%)
|
2.49B
2.49B – 2.49B
-33.9% YoY
|
2.59B
2.59B – 2.59B
+4.0% YoY
|
2.68B
2.68B – 2.68B
+3.2% YoY
|
| EBIT |
3.77B
est: 828.38M (+355.1%)
|
3.91B
est: 1.34B (+191.2%)
|
1.94B
est: 2.02B (-3.8%)
|
1.29B
est: 2.14B (-39.4%)
|
4.90B
est: 1.39B (+253.1%)
|
2.12B
est: 1.24B (+71.0%)
|
-1.18B
est: 1.08B (-209.5%)
|
576.42M
est: 1.41B (-59.1%)
|
1.14B
est: 1.37B (-16.4%)
|
905.21M
905.21M – 905.21M
-33.9% YoY
|
941.41M
941.41M – 941.41M
+4.0% YoY
|
971.45M
971.45M – 971.45M
+3.2% YoY
|
| Net Income |
2.40B
est: 3.84B (-37.4%)
|
2.43B
est: 3.07B (-20.8%)
|
382.97M
est: 2.83B (-86.5%)
|
144.53M
est: 163.13M (-11.4%)
|
2.75B
est: 3.17B (-13.4%)
|
776.28M
est: 953.02M (-18.5%)
|
-2.87B
est: -1.29B (-122.5%)
|
-976.52M
est: 154.54M (-731.9%)
|
-288.75M
est: 849.99M (-134.0%)
|
412.12M
412.12M – 412.12M
-51.5% YoY
|
746.96M
746.96M – 746.96M
+81.3% YoY
|
1.00B
1.00B – 1.00B
+34.5% YoY
|
| SGA |
3.19B
est: 2.44B (+30.4%)
|
3.28B
est: 3.96B (-17.3%)
|
3.44B
est: 5.94B (-42.1%)
|
3.22B
est: 6.30B (-48.9%)
|
3.21B
est: 4.09B (-21.6%)
|
3.62B
est: 3.65B (-0.9%)
|
3.41B
est: 3.19B (+7.0%)
|
3.23B
est: 4.16B (-22.4%)
|
3.18B
est: 4.04B (-21.2%)
|
2.67B
2.67B – 2.67B
-33.9% YoY
|
2.78B
2.78B – 2.78B
+4.0% YoY
|
2.87B
2.87B – 2.87B
+3.2% YoY
|
| EPS |
1.07
est: 1.49 (-28.2%)
|
1.08
est: 1.19 (-9.2%)
|
0.18
est: 1.10 (-83.6%)
|
0.07
est: 0.06 (+6.3%)
|
1.18
est: 1.23 (-4.3%)
|
0.30
est: 0.37 (-18.9%)
|
-1.11
est: -0.50 (-122.0%)
|
-0.38
est: 0.06 (-733.3%)
|
-0.11
est: 0.33 (-133.3%)
|
0.16
0.16 – 0.16
-51.5% YoY
|
0.29
0.29 – 0.29
+81.3% YoY
|
0.39
0.39 – 0.39
+34.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-25 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 66.6K | 0.46% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 265.2K | 0.39% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 158.4K | 0.29% |
| 4 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 129.9K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bin Feng | Chief Engineer | — | male |
| Bin Ma | Deputy General Manager | — | male |
| Chao Xiu Huang | Accounting Supervisor | — | — |
| Fen Xue | Deputy GM & Company Secretary | — | female |
| Jun Jiang | GM & Director | — | male |
| Xiu Cai Ji | Deputy General Manager | — | male |
| Zengwei Huang | Chief Financial Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002092.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
